欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号PT/H/2173/002
药品名称Daptomicina Accordpharma
活性成分
    • Daptomycin 500.0 mg
剂型Powder for solution for infusion/injection
上市许可持有人Accord Healthcare S.L.U.
参考成员国 - 产品名称Portugal (PT)
Daptomicina Accordpharma
互认成员国 - 产品名称
    • Poland (PL)
      Daptomycin Astron
    • Czechia (CZ)
      Daptomycin Astron
    • Slovenia (SI)
      Daptomicin Accordpharma 500 mg prašek za raztopino za injiciranje/infundiranje
    • Croatia (HR)
      Daptomicin Accordpharma 500 mg prašak za otopinu za injekciju/infuziju
    • France (FR)
    • United Kingdom (Northern Ireland) (XI)
    • Italy (IT)
    • Germany (DE)
      Daptomycin Accordpharma 500 mg Pulver zur Herstellung einer Injektions-/Infusionlösung
    • Spain (ES)
    • Denmark (DK)
      Daptomycin Astron
    • Netherlands (NL)
      Daptomycine Accordpharma 500 mg poeder voor oplossing voor injectie/infusie
    • Ireland (IE)
    • Austria (AT)
      Daptomycin Accordpharma 500 mg Pulver zur Herstellung einer Injektions-/Infusionslösung
    • Greece (GR)
    • Sweden (SE)
    • Norway (NO)
      Daptomycin Accordpharma
    • Finland (FI)
许可日期2019/10/15
最近更新日期2025/01/27
药物ATC编码
    • J01XX09 daptomycin
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase